Protagenic Therapeutics Inc. (PTIXW) Business News Nov. 13, 2025, 13:22 UTC Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study Full text
Register to leave comments News bot Nov. 13, 2025, 1:30 p.m. 📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical